Thermo Fisher and Artificial collaborate on COVID-19 testing platform
March 25, 2021
Thermo Fisher Scientific and Artificial, a developer of automation software, have formed a strategic technology collaboration to develop an integrated and comprehensive software automation platform for Thermo Fisher's standardized COVID-19 Testing Platform, according to a news release.
As part of the collaboration, Artificial will provide access to its aLab Suite software, which is designed to integrate with Thermo Scientific Momentum Workflow software and robotics hardware.
The aLab Suite software facilitates the scheduling of protocol runs with batch optimization. In addition, the manual system set-up steps associated with Momentum’s process execution can be coordinated using aLab digital assistants to reduce the need for user input.
